Implementing Measurement-Based Care to Determine and Treat Inadequate Response [0.03%]
基于测量的护理的实施以确定和治疗不足的反应
Madhukar H Trivedi,George I Papakostas,W Clay Jackson et al.
Madhukar H Trivedi et al.
Measurement-based care (MBC) is an important strategy in the treatment of patients with major depressive disorder who have inadequate antidepressant response. The rating scales used in MBC can assist clinicians at critical decision poi...
Identifying and Treating Insomnia in Patients Living With Alzheimer's Disease [0.03%]
阿尔茨海默病患者失眠的识别与治疗
Alon Avidan,Anna Burke
Alon Avidan
The number of patients with Alzheimer's disease (AD) is increasing significantly. The disease affects many aspects of a person's life, and often sleep disturbances are problematic for the patient and for their family. It is critical for cli...
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2) [0.03%]
氯胺酮鼻喷雾剂联合口服抗抑郁药治疗难治性抑郁症：一项开放标签III期研究(SUSTAIN-2)的长期安全性评估
Ewa Wajs,Leah Aluisio,Richard Holder et al.
Ewa Wajs et al.
Objective: To evaluate long-term safety and efficacy of esketamine nasal spray plus a new oral antidepressant (OAD) in patients with treatment-resistant depression (TRD). ...
Addressing the Experience of Children and Adolescents During the COVID-19 Pandemic [0.03%]
新冠肺炎疫情下的儿童及青少年体验应对措施
Karen Dineen Wagner
Karen Dineen Wagner
Machine Learning Algorithms in Suicide Prevention: Clinician Interpretations as Barriers to Implementation [0.03%]
机器学习算法在自杀预防中的临床医生解释障碍 IMPLEMENTATION障碍
Lily A Brown,Kathy Benhamou,Alexis M May et al.
Lily A Brown et al.
Objective: Machine learning algorithms in electronic medical records can classify patients by suicide risk, but no research has explored clinicians' perceptions of suicide risk flags generated by these algorithms, which m...
Christoph U Correll
Christoph U Correll
The currently available antipsychotics mostly treat the positive symptoms of schizophrenia and have at least one adverse effect as a potential liability. Encouraging data suggest potential efficacy for a variety of new agents for the treatm...
Using Patient-Centered Assessment in Schizophrenia Care: Defining Recovery and Discussing Concerns and Preferences [0.03%]
以患者为中心的精神分裂症护理评估：定义康复及讨论关注点和偏好
Christoph U Correll
Christoph U Correll
Syndromal recovery, satisfactory quality of life, and adequate functionality are relevant goals that define successful treatment of schizophrenia. Recovery requires effective symptom control in multiple clinical domains but also sufficient ...
Efficacy and Safety of Guanfacine Extended-Release in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled Study [0.03%]
一项成人注意缺陷多动障碍的随机双盲安慰剂对照研究：苯异妥英缓释片治疗的疗效和安全性
Akira Iwanami,Kazuhiko Saito,Masakazu Fujiwara et al.
Akira Iwanami et al.
Objective: To assess guanfacine extended-release (GXR) efficacy and safety in adults with attention-deficit/hyperactivity disorder (ADHD). Methods: ...
Keep Socially (but Not Physically) Connected and Carry on: Preventing Suicide in the Age of COVID-19 [0.03%]
保持社交联系（而不是身体接触）继续前行：预防COVID-19时代的自杀事件
Philippe Courtet,Emilie Olié,Christophe Debien et al.
Philippe Courtet et al.
COVID-19: Humanitarian and Health Care Crisis in a Third World Country [0.03%]
新冠肺炎疫情下的第三世界国家的人道主义和医疗卫生危机
Chittaranjan Andrade
Chittaranjan Andrade